Table 1.
Sample characteristics.
| Mean ± SD or n (%) |
P-value | |||||
|---|---|---|---|---|---|---|
| Total | Year of study |
|||||
| n=247 | First Year | Second Year | Third Year | Fourth Year | ||
| 90 (36.4) | 66 (26.7) | 61 (24.7) | 30 (12.2) | |||
| HPV and the Vaccine Knowledge | 19.4 ± 4.6 | 16.2 ± 5.1 | 19.1 ± 3.6 | 22.2 ± 1.9 | 23.3 ± 1.6 | <.0001 |
| HPV-associated HNC Knowledge | 7.2 ± 2.1 | 6.0 ± 1.9 | 7.4 ± 1.8 | 8.0 ± 1.8 | 8.7 ± 1.9 | <.0001 |
| HPV causes HNC | <.0001 | |||||
| Yes | 53 (21.5) | 6 (6.7) | 16 (24.2) | 20 (32.8) | 11 (36.7) | |
| No | 194 (78.5) | 84 (93.3) | 50 (75.8) | 41 (67.2) | 19 (63.3) | |
| HPV causes Cervical Cancer | <.0001 | |||||
| Yes | 179 (72.5) | 48 (53.3) | 51 (77.3) | 56 (91.8) | 24 (80.0) | |
| No | 68 (27.5) | 42 (46.7) | 15 (22.7) | 5 (8.2) | 6 (20.0) | |
| Age | 24.0 ± 1.3 | 23.0 ± 1.2 | 23.8 ± 1.1 | 24.8 ± 0.8 | 25.5 ± 0.6 | <.0001 |
| Sex | .1107 | |||||
| Female | 139 (56.1) | 54 (60.0) | 41 (62.1) | 26 (42.6) | 17 (56.7) | |
| Male | 109 (43.9) | 36 (40.0) | 25 (37.9) | 35 (57.4) | 13 (43.3) | |
| Race | .2138 | |||||
| White | 149 (60.1) | 52 (57.8) | 36 (54.5) | 37 (60.7) | 23 (76.7) | |
| Nonwhite | 99 (39.9) | 38 (42.2) | 30 (45.5) | 24 (39.3) | 7 (23.3) | |
| Marital status | .0026 | |||||
| Married | 119 (48.0) | 39 (43.3) | 37 (56.1) | 33 (54.1) | 10 (33.3) | |
| Single but Dating | 50 (20.2) | 18 (20.0) | 11 (16.7) | 6 (9.8) | 14 (46.7) | |
| Single and not Dating | 79 (31.8) | 33 (36.7) | 18 (27.3) | 22 (36.1) | 6 (20.1) | |
| Number of oral sexual partners | .6735 | |||||
| None | 57 (23.1) | 25 (27.8) | 13 (19.7) | 15 (24.6) | 4 (13.3) | |
| One | 60 (24.3) | 18 (20.0) | 18 (27.3) | 16 (26.2) | 8 (26.7) | |
| ≥Two | 130 (52.6) | 47 (52.2) | 35 (53.0) | 30 (49.2) | 18 (60.0) | |
| Number of vaginal sexual partners | .5188 | |||||
| None | 82 (33.2) | 36 (40.0) | 20 (30.3) | 19 (31.2) | 7 (23.3) | |
| One | 69 (27.9) | 19 (21.1) | 22 (33.3) | 18 (29.5) | 10 (33.3) | |
| ≥Two | 96 (38.9) | 35 (38.9) | 24 (36.4) | 24 (39.3) | 13 (43.3) | |
| Physician recommendation of HPV vaccine | .0336 | |||||
| Yes | 129 (52.0) | 54 (60.0) | 36 (54.5) | 22 (36.1) | 16 (53.3) | |
| No | 119 (48.0) | 36 (40.0) | 30 (45.5) | 39 (63.9) | 14 (46.7) | |
| HPV vaccine initiation | .4235 | |||||
| Yes | 124 (50.0) | 46 (51.1) | 35 (53.0) | 25 (41.0) | 17 (56.7) | |
| No | 124 (50.0) | 44 (48.9) | 31 (47.0) | 36 (59.0) | 13 (43.3) | |
| HPV vaccine completion | .3199 | |||||
| Yes | 102 (41.1) | 40 (44.4) | 29 (43.9) | 19 (31.2) | 14 (46.7) | |
| No | 146 (58.9) | 50 (55.6) | 37 (56.1) | 42 (68.8) | 16 (53.3) | |
| Specialty | .3562 | |||||
| Pediatrics | 48 (19.4) | 19 (21.1) | 10 (15.2) | 11 (18.0) | 8 (26.7) | |
| Family Medicine | 26 (10.5) | 8 (9.1) | 6 (9.1) | 9 (14.8) | 3 (10.0) | |
| Internal Medicine | 64 (25.9) | 23 (25.6) | 15 (22.7) | 16 (26.2) | 10 (33.3) | |
| Surgery | 41 (16.6) | 17 (18.9) | 8 (12.1) | 10 (16.4) | 6 (20.0) | |
| Other specialties | 68 (27.5) | 23 (25.6) | 27 (40.9) | 15 (24.6) | 3 (10.0) | |
HPV = Human Papillomavirus; HNC = Head and Neck Cancer.